Protective effects of p53-regulating agents against high-LET radiation-induced injury in mice

Yuichi Nishiyama, 根井充, Tatsuro Teraoka(Tokyo University of Pharmacy and Life Sciences), Takanori Katsube(National Institutes for Quantum Science and Technology), Akinori Morita(Hiroshima University), 田中薫, Dwi Ramadhani, 村上正弘, 下川卓志, Mitsuru Nenoi, Ochi Shintaro, Kaoru Tanaka(Kindai University), Ramadhani Dwi, 越智進太郎, Aoki Shin, 王冰, 勝部孝則, Masahiro Murakami, Bing Wang, Takashi Shimokawa(National Institutes for Quantum Science and Technology)

Institutional Repositories DataBase (IRDB)

August 17, 2018

Cited by 0

Related Papers

Association of Immune-Related Adverse Events With Nivolumab Efficacy in Non–Small-Cell Lung Cancer

|JAMA Oncology|2017|1k

Tumor immune microenvironment and nivolumab efficacy in EGFR mutation-positive non-small-cell lung cancer based on T790M status after disease progression during EGFR-TKI treatment

|Annals of Oncology|2017|294

Impact of EGFR-TKI Treatment on the Tumor Immune Microenvironment in <i>EGFR</i> Mutation–Positive Non–Small Cell Lung Cancer

|Clinical Cancer Research|2020|244

Peripheral Blood Biomarkers Associated with Clinical Outcome in Non–Small Cell Lung Cancer Patients Treated with Nivolumab

|Journal of Thoracic Oncology|2017|227

Space Radiation Biology for “Living in Space”

|BioMed Research International|2020|181